Pain Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch PTIE and buy or sell other stocks, options, and ETFs commission-free!About PTIE
Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx.
CEORemi Barbier, MBA
CEORemi Barbier, MBA
Employees—
Employees—
HeadquartersAustin, Texas
HeadquartersAustin, Texas
Founded1998
Founded1998
Employees—
Employees—
PTIE Key Statistics
Market cap915.94M
Market cap915.94M
Price-Earnings ratio-9.14
Price-Earnings ratio-9.14
Dividend yield—
Dividend yield—
Average volume1.34M
Average volume1.34M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$32.10
52 Week high$32.10
52 Week low$12.32
52 Week low$12.32